• 1
    World Health Organization. WHO Diabetes Fact Sheet. 2011 [22/08/2011]; Available at Last accessed 22 August 2011.
  • 2
    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care2004; 27: 10471053.
  • 3
    International Diabetes Federation. IDF Diabetes Atlas – The Economic Impacts of Diabetes. 2010. Available at Last accessed 22 August 2011.
  • 4
    Levin M, Pfeifer M. Uncomplicated Guide To Diabetes Complications, 3 edn. Alexandria: American Diabetes Association, 2009.
  • 5
    Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet2005; 365: 13331346.
  • 6
    Sutherland JE, Hoehns JD. Treating type 2 diabetes: targeting the many causative factors. J Fam Pract2004; 53: 376388.
  • 7
    Centers for Disease Control and Prevention, eds. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
  • 8
    Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care2004; 27: 12181224.
  • 9
    Alvarez Guisasola F, Tofe Povedano S, Krishnarajah G, Lyu R, Mavros P, Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab2008; 10(Suppl 1): 2532.
  • 10
    Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ2007; 33: 10141029.
  • 11
    Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care2003; 26: 14081412.
  • 12
    Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of Type 2 diabetes. Int J Clin Pract2011; 65: 314322.
  • 13
    Dham S, Shah V, Hirsch S, Banerji MA. The role of complementary and alternative medicine in diabetes. Curr Diab Rep2006; 6: 251258.
  • 14
    Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health2002; 92: 15821591.
  • 15
    Bell RA, Suerken CK, Grzywacz JG, Lang W, Quandt SA, Arcury TA. Complementary and alternative medicine use among adults with diabetes in the United States. Altern Ther Health Med2006; 12: 1622.
  • 16
    Bantle JP, Wylie-Rosett J, Albright AL, Apovian CM, Clark NG, Franz MJ et al.Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care2008; 31(Suppl 1): S61S78.
  • 17
    Samad A, Shams MS, Ullah Z, Wais M, Nazish I, Sultana Y et al.Status of herbal medicines in the treatment of diabetes: a review. Curr Diabetes Rev2009; 5: 102111.
  • 18
    Jayaprakasha G, Jagan Mohan Rao L. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit Rev Food Sci Nutr2011; 51: 547562.
  • 19
    Ouattara B, Simard RE, Holley RA, Piette GJ, Begin A. Antibacterial activity of selected fatty acids and essential oils against six meat spoilage organisms. Int J Food Microbiol1997; 37: 155162.
  • 20
    Gruenwald J, Freder J, Armbruester N. Cinnamon and health. Crit Rev Food Sci Nutr2010; 50: 822834.
  • 21
    Cao H, Polansky MM, Anderson RA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys2007; 459: 214222.
  • 22
    Qin B, Nagasaki M, Ren M, Bajotto G, Oshida Y, Sato Y. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract2003; 62: 139148.
  • 23
    Baker WL, Gutierrez-Williams G, White CM, Kluger J, Coleman CI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care2008; 31: 4143.
  • 24
    Archer A. Determination of cinnamaldehyde, coumarin and cinnamyl alcohol in cinnamon and cassia by high-performance liquid chromatography. J Chromatogr1988; 447: 272276.
  • 25
    Abraham K, Wohrlin F, Lindtner O, Heinemeyer G, Lampen A. Toxicology and risk assessment of coumarin: focus on human data. Mol Nutr Food Res2010; 54: 228239.
  • 26
    European Food Safety Association. Coumarin in flavourings and other food ingredients with flavouring properties. EFSA J2008; 793: 115.
  • 27
    The PRISMA GroupMoher D, Liberati A, Tetzlaff J, Altman DG, . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med2009; 6: e1000097.
  • 28
    Cochran WG. The combination of estimates from different experiments. Biometrics1954; 10: 101129.
  • 29
    Higgins IP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med2002; 21: 15391558.
  • 30
    Al-Logmani AS, Zari TA. Effects of Nigella sativa L. and Cinnamomum zeylanicum Blume oils on some physiological parameters in streptozotocin-induced diabetic rats. Bol Latinoam Caribe Plantas M2009; 8: 8696.
  • 31
    Anand P, Murali KY, Tandon V, Murthy PS, Chandra R. Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats. Chemico-Biolog Interact2010; 186: 7281.
  • 32
    Gumy C, Thurnbichler C, Aubry EM, Balazs Z, Pfisterer P, Baumgartner L et al.Inhibition of 11[beta]-hydroxysteroid dehydrogenase type 1 by plant extracts used as traditional antidiabetic medicines. Fitoterapia2009; 80: 200205.
  • 33
    Mishra A, Bhatti R, Singh A, Singh Ishar MP. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med2010; 76: 412417.
  • 34
    Rajbir B, Kaur S, Singh J, Ishar MPS. Ameliorative effect of volatile oil from Cinnamomum zeylanicum on hyperalgesia in alloxan diabetic rats. Can J Pure Appl Sci2009; 3: 887895.
  • 35
    Ranilla LG, Kwon YI, Apostolidis E, Shetty K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour Technol2010; 101: 46764689.
  • 36
    Roffey B, Atwal A, Kubow S. Cinnamon water extracts increase glucose uptake but inhibit adiponectin secretion in 3T3-L1 adipose cells. Mol Nutr Food Res2006; 50: 739745.
  • 37
    Shen Y, Fukushima M, Ito Y, Muraki E, Hosono T, Seki T et al.Verification of the antidiabetic effects of cinnamon (Cinnamomum zeylanicum) using insulin-uncontrolled type 1 diabetic rats and cultured adipocytes. Biosci Biotechnol Biochem2010; 74: 24182425.
  • 38
    Soonham SY, Samir MK. Effect of cinnamon on plasma glucose concentration and the regulation of 6-phosphofructo-1-kinase activity from the liver and small intestine of streptozotocin induced diabetic rats. J Biolog Sci2010; 10: 761766.
  • 39
    Subash Babu P, Prabuseenivasan S, Ignacimuthu S. Cinnamaldehyde – a potential antidiabetic agent. Phytomedicine2007; 14: 1522.
  • 40
    Taher M, Fadzilah AAM, Mohomad RS. A proanthocyanidin from Cinnamomum zeylanicum stimulates phosphorylation of insulin receptor in 3T3-L1 adipocytes. J Teknologi2006; 44: 5368.
  • 41
    Verspohl EJ, Bauer K, Neddermann E. Antidiabetic effect of Cinnamomum cassia and Cinnamomum zeylanicum in vivo and in vitro. Phytother Res2005; 19: 203206.
  • 42
    Zari TA, Al-Logmani AS. Long-term effects of Cinnamomum zeylanicum Blume oil on some physiological parameters in streptozotocin-diabetic and non-diabetic rats. Bol Latinoam Caribe Plantas M2009; 8: 266274.
  • 43
    Adisakwattana S, Lerdsuwankij O, Poputtachai U, Minipun A, Suparpprom C. Inhibitory activity of cinnamon bark species and their combination effect with acarbose against intestinal α-glucosidase and pancreatic α-amylase. Plant Foods Hum Nutr2011; 66: 143148.
  • 44
    Kannappan S, Jayaraman T, Rajasekar P, Ravichandran MK, Anuradha CV. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J2006; 47: 858863.
  • 45
    Shihabudeen MS, Priscilla H, Thirumurugan K. Cinnamon extract inhibits alpha-glucosidase activity and dampens postprandial glucose excursion in diabetic rats. Nutr Metab (Lond)2011; 8: 46.
  • 46
    Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J2008; 22: 659661.
  • 47
    Jayaprakasha JK, Negia PS, Jena BS, Jagan Mohan Rao L. Antioxidant and antimutagenic activities of Cinnamomum zeylanicum fruit extracts. J Food Comp Anal2007; 20: 330336.
  • 48
    Vats V, Yadav SP, Grover JK. Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats. J Ethnopharmacol2004; 90: 155160.
  • 49
    Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology2007; 132: 21692180.
  • 50
    Joshi K, Awte S, Bhatnagar P, Walunj S, Gupta R, Joshi S et al. Cinnamomum zeylanicum extract inhibits proinflammatory cytokine TNFμ: in vitro and in vivo studies. Pharmaceut Biotechnol2010; 2: 1421.
  • 51
    Peng X, Ma J, Chao J, Sun Z, Chang RC, Tse I et al.Beneficial effects of cinnamon proanthocyanidins on the formation of specific advanced glycation endproducts and methylglyoxal-induced impairment on glucose consumption. J Agric Food Chem2010; 58: 66926696.
  • 52
    Anderson RA. Chromium and polyphenols from cinnamon improve insulin sensitivity. Proc Nutr Soc2008; 67: 4853.
  • 53
    Witters LA. The blooming of the French lilac. J Clin Invest2001; 108: 11051107.
  • 54
    Modak M, Dixit P, Londhe J, Ghaskadbi S, Paul ADT. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr2007; 40: 16373.
  • 55
    Rudkowska I. Functional foods for health: focus on diabetes. Maturitas2009; 62: 263269.
  • 56
    Altschuler JA, Casella SJ, MacKenzie TA, Curtis KM. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care2007; 30: 813816.
  • 57
    Zhang W, Xu YC, Guo FJ, Meng Y, Li ML. Anti-diabetic effects of cinnamaldehyde and berberine and their impacts on retinol-binding protein 4 expression in rats with type 2 diabetes mellitus. Chin Med J (Engl)2008; 121: 21242128.